Wenxin Xu
机构：Fudan University, Ministry of Education · ORCID：0009-0007-7312-4302
发表论文 38 篇 · 总被引 227 次 · h-index 7
代表论文
- ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis (2024 · Cancer Research · 被引 33)
- AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization (2024 · Journal for ImmunoTherapy of Cancer · 被引 30)
- Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers (2025 · Journal of Experimental & Clinical Cancer Research · 被引 14)
- Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma (2025 · Gut · 被引 10)
- FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma (2024 · The Oncologist · 被引 10)
- Data from ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis (2025 · 被引 1)